Randomized trials published in chinese or western journals: Comparative empirical analysis

Journal of Clinical Psychopharmacology

Volumn 32, Issue 3, 2012, Pages 354-361

  Purgato, Marianna ^a   Cipriani, Andrea ^a   Barbui, Corrado ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

antidepressant drugs; major depression; meta analysis; quality

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYPERICUM EXTRACT; IMIPRAMINE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; PAROXETINE; REBOXETINE; SERTRALINE; VENLAFAXINE;

CHINA; CLINICAL GLOBAL IMPRESSION SCALE; DISEASE REGISTRY; DRUG EFFICACY; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MEDICAL LITERATURE; META ANALYSIS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

ADULT; ANTIDEPRESSIVE AGENTS; BIOMEDICAL RESEARCH; CHINA; DATABASES, BIBLIOGRAPHIC; DEPRESSIVE DISORDER, MAJOR; HUMANS; PERIODICALS AS TOPIC; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; WESTERN WORLD;

EID: 84861047112     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182546ef6     Document Type: Review

References (26)

1. Zhang D, Yin P, Freemantle N, et al. An assessment of the quality of randomised controlled trials conducted in China. Trials. 2008;9:22.
2. Xu L, Li J, Zhang M, et al. Chinese authors do need CONSORT: Reporting quality assessment for five leading Chinese medical journals. Contemp Clin Trials. 2008;29:727-731.
3. Zhang D, Freemantle N, Cheng KK. Are randomized trials conducted in China or India biased? A comparative empirical analysis. J Clin Epidemiol. 2011;64:90-95.
4. Barbui C, Hotopf M. Forty years of antidepressant drug trials. Acta Psychiatr Scand. 2001;104:92-95.
5. Melander H, hlqvist-Rastad J, Meijer G, et al. Evidence b(i)ased medicineVselective reporting from studies sponsored by pharmaceutical industry: Review of studies in new drug applications. BMJ. 2003;326:1171-1173.
6. Barbui C, Cipriani A, Brambilla P, et al. "Wish bias" in antidepressant drug trials? J Clin Psychopharmacol. 2004;24:126-130.
7. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
8. Cipriani A, Malvini L, Furukawa TA, et al. Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: Systematic review, meta-analysis, and meta-regression analysis. J Clin Psychopharmacol. 2007;27:352-356.
9. Cipriani A, Purgato M, Furukawa T, et al. Citalopram versus other anti-depressive agents for depression. Cochrane Database Syst Rev. In press.
10. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009;339:b2535.
11. Higgins J, Altman D. Assessing risk of bias in included studies. In: Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. Chichester, UK: John Wiley & Sons, Ltd; 2008.
12. Norman GR. Issues in the use of change scores in randomized trials. J Clin Epidemiol. 1989;42:1097-1105.
13. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. Chichester, UK: John Wiley & Sons, Ltd; 2008.
14. Altman DG, Bland JM. Detecting skewness from summary information. BMJ. 1996; 313: 1200.
15. Furukawa TA, Barbui C, Cipriani A, et al. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol. 2006;59:7-10.
16. Furukawa TA, Cipriani A, Barbui C, et al. Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol. 2005;20:49-52.
17. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis. Lancet. 2009;373:746-758.
18. Xia J, Wright J, Adams CE. Five large Chinese biomedical bibliographic databases: Accessibility and coverage. Health Info Libr J. 2008;25:55-61.
19. White C. WHO database to include drug trials in China and India. BMJ. 2007;335:226-227.
20. Wu T, Li Y, Bian Z, et al. Randomized trials published in some Chinese journals: How many are randomized? Trials. 2009;10:46.
21. Duan Y, Li J, Ai C, et al. Quality of trials reported as conference abstracts in China: How well are they reported? Int J Technol Assess Health Care. 2009;25:479-484.
22. Chen Y, Li J, Ai C, et al. Assessment of the quality of reporting in abstracts of randomized controlled trials published in five leading Chinese medical journals. PLoS One. 2010;5:e11926.
23. Purgato M, Barbui C, Cipriani A. Assessing risk of bias in randomized controlled trials. Epidemiol Psichiatr Soc. 2010;19:296-297.
24. Chakrabarti A, Adams CE, Rathbone J, et al. Schizophrenia trials in China: A survey. Acta Psychiatr Scand. 2007;116:6-9.
25. Koesters M, Zhang Y, Chun Y, et al. What can we learn from Chinese randomized controlled trials? A systematic review and meta-analysis of Chinese venlafaxine studies. J Clin Psychopharmacol. 2011;31:194-200.
26. Nuesch E, Trelle S, Reichenbach S, et al. The effects of excluding patients from the analysis in randomised controlled trials: Meta-epidemiological study. BMJ. 2009;339:b3244.